These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1577042)

  • 1. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination.
    Akopov SE; Gabrielian ES
    Eur J Clin Pharmacol; 1992; 42(3):257-9. PubMed ID: 1577042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
    Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
    Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of co-dergocrine on platelet aggregation.
    Santos RO; Rodrigues R
    Braz J Med Biol Res; 1990; 23(3-4):325-7. PubMed ID: 2094545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of ginger and nifedipine on human platelet aggregation: a study in hypertensive patients and normal volunteers.
    Young HY; Liao JC; Chang YS; Luo YL; Lu MC; Peng WH
    Am J Chin Med; 2006; 34(4):545-51. PubMed ID: 16883626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the association dipyridamole-aspirin only act by a functional synergism?
    De la Cruz JP; Sanchez de la Cuesta F
    Gen Pharmacol; 1991; 22(2):271-4. PubMed ID: 2055420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
    Zhao L; Bath P; Heptinstall S
    Br J Pharmacol; 2001 Sep; 134(2):353-8. PubMed ID: 11564653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
    May JA; Heptinstall S; Cole AT; Hawkey CJ
    Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of the combination of aspirin and nifedipine on platelet aggregation and thrombogenesis].
    Dong E; Shi S
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):301-3, 319. PubMed ID: 2086198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
    Heptinstall S; Fox S; Crawford J; Hawkins M
    Thromb Res; 1986 Apr; 42(2):215-23. PubMed ID: 3715801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,3-diphosphoglycerate: a physiological inhibitor of platelet aggregation.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Science; 1975 Jan; 187(4173):259-61. PubMed ID: 1111100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro platelet aggregation and its inhibition by three antithrombotic drugs between human and guinea pig.
    Huang ZS; Lee TK
    Proc Natl Sci Counc Repub China B; 1991 Feb; 15(1):8-14. PubMed ID: 1946813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the degradation of prostacyclin in blood and antiplatelet drug effects in patients with atherosclerosis.
    Akopov SE; Gabrielian ES
    J Clin Pharmacol; 1993 Nov; 33(11):1048-51. PubMed ID: 8300887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased whole blood platelet aggregation in normal pregnancy can be prevented in vitro by aspirin and dazmegrel (UK38485).
    Norris LA; Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1992 Mar; 99(3):253-7. PubMed ID: 1606123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
    Glusa E; Bevan J; Heptinstall S
    Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suloctidil: a novel inhibitor of platelet aggregation in human beings.
    de Gaetano G; Miragliotta G; Roncucci R; Lansen J; Lambelin G
    Thromb Res; 1976 Mar; 8(3):361-71. PubMed ID: 1265708
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-dependent aspirin hydrolysis and platelet aggregation in patients with atherosclerosis.
    Akopov SS; Grigorian GS; Gabrielian ES
    J Clin Pharmacol; 1992 Feb; 32(2):133-5. PubMed ID: 1613122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
    Sudo T; Ito H; Ozeki Y; Kimura Y
    Br J Pharmacol; 2001 Aug; 133(8):1396-404. PubMed ID: 11498527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.